BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Mosliciguat readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Mosliciguat\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07333183-544@assetmemo.bio
DTSTAMP:20261121T005627Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Mosliciguat: Phase 2 readout est. (NCT07333183)
DESCRIPTION:Mosliciguat\, phase 2\, Pulmonary Hypertension Associated with 
 Interstitial Lung Disease.\nStudy: A Study of Mosliciguat in Combination W
 ith Inhaled Treprostinil in PH-ILD\nEstimated primary completion: December
  2026. This is a ClinicalTrials.gov estimate\, not a confirmed readout dat
 e\, and it can move.\nDrug page: https://assetmemo.bio/drug/mosliciguat#up
 coming-events\nRegistry record: https://clinicaltrials.gov/study/NCT073331
 83
URL:https://assetmemo.bio/drug/mosliciguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07816185-544@assetmemo.bio
DTSTAMP:20261121T005627Z
DTSTART;VALUE=DATE:20290128
DTEND;VALUE=DATE:20290129
SUMMARY:Mosliciguat: Phase 3 readout est. (NCT07816185)
DESCRIPTION:Mosliciguat\, phase 3\, Pulmonary Hypertension Associated with 
 Interstitial Lung Disease.\nStudy: A Phase 3 Trial of Inhaled Mosliciguat 
 in PH-ILD (PHrontier)\nEstimated primary completion: 28 January 2029. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/mosliciguat#upcoming-even
 ts\nRegistry record: https://clinicaltrials.gov/study/NCT07816185
URL:https://assetmemo.bio/drug/mosliciguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
